MRNA peer analysis
Moderna (MRNA) against its competitors: price, today's move, 1-year return and market value side by side.
MRNA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $11.03 | -9.22% | 14.54% | $313.51M |
| BNTX BioNTech | $87.55 | -0.70% | -16.25% | $22.15B |
| GSK GSK | $49.19 | -0.66% | 4.75% | $99.19B |
| INO Inovio | $1.99 | 230.35% | -16.10% | $62.29M |
| NVAX Novavax | $9.53 | -5.46% | 14.47% | $1.66B |
| OGEN Oragenics | $0.37 | -0.05% | -71.23% | $1.69M |
| PCVX Vaxcyte | $60.68 | -2.18% | 35.64% | $9.76B |
| PFE Pfizer | $30.93 | 1.36% | 27.34% | $173.95B |
| VALN Valneva | $5.45 | -4.55% | -40.24% | – |
| VIR Vir Biotechnology | $11.12 | -1.59% | 89.38% | $1.91B |
| MRNA Moderna | $218.94 | -1.25% | 692.11% | $88.52B |
- MRNA's peers: ARCT (Arcturus), BNTX (BioNTech), GSK (GSK), INO (Inovio), NVAX (Novavax), OGEN (Oragenics), PCVX (Vaxcyte), PFE (Pfizer).
Updated 2026-11-02 20:40 UTC